These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26061747)

  • 21. The EMT-activator ZEB1 is unrelated to platinum drug resistance in ovarian cancer but is predictive of survival.
    Rae S; Spillane C; Blackshields G; Madden SF; Keenan J; Stordal B
    Hum Cell; 2022 Sep; 35(5):1547-1559. PubMed ID: 35794446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
    Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
    Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
    Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
    Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Int J Cancer; 2011 Jan; 128(1):94-104. PubMed ID: 20309881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-181a upregulation is associated with epithelial-to-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells.
    Li L; Xu QH; Dong YH; Li GX; Yang L; Wang LW; Li HY
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2004-10. PubMed ID: 27249598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells.
    Park GB; Chung YH; Kim D
    Oncol Rep; 2017 May; 37(5):3137-3145. PubMed ID: 28350104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition.
    Chen C; Huang S; Chen CL; Su SB; Fang DD
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31623144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1.
    Carriere PP; Llopis SD; Naiki AC; Nguyen G; Phan T; Nguyen MM; Preyan LC; Yearby L; Pratt J; Burks H; Davenport IR; Nguyen TA; Parker-Lemieux K; Payton-Stewart F; Williams CC; Boué SM; Burow ME; Collins-Burow B; Hilliard A; Davidson AM; Tilghman SL
    Int J Environ Res Public Health; 2015 Dec; 13(1):ijerph13010010. PubMed ID: 26703648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
    Yi BR; Kim TH; Kim YS; Choi KC
    Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arborinine suppresses ovarian cancer development through inhibition of LSD1.
    Li N; Yang L; Zuo H
    Life Sci; 2022 Feb; 291():120275. PubMed ID: 34979197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis.
    Smit MA; Peeper DS
    Oncogene; 2011 Sep; 30(35):3735-44. PubMed ID: 21478908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells.
    Law AY; Wong CK
    Exp Cell Res; 2010 Dec; 316(20):3425-34. PubMed ID: 20619259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype.
    Rohnalter V; Roth K; Finkernagel F; Adhikary T; Obert J; Dorzweiler K; Bensberg M; Müller-Brüsselbach S; Müller R
    Oncotarget; 2015 Nov; 6(37):40005-25. PubMed ID: 26503466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.
    Ponnusamy MP; Lakshmanan I; Jain M; Das S; Chakraborty S; Dey P; Batra SK
    Oncogene; 2010 Oct; 29(42):5741-54. PubMed ID: 20697346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.